Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 462 | 509 | 936 | 1,115 | 917 |
| Gross Profit | 462 | 509 | 936 | 1,115 | 917 |
| Operating Expenses | 7,401 | 6,423 | 5,018 | 4,565 | 4,458 |
| Operating Income | -6,939 | -5,914 | -4,082 | -3,450 | -3,541 |
| Interest Expense | 71 | 76 | 78 | 83 | 89 |
| Other Income | 30 | 16 | 7 | 9 | 7 |
| Pre-tax Income | -6,980 | -5,974 | -4,153 | -3,524 | -3,623 |
| Net Income Continuous | -6,980 | -5,974 | -4,153 | -3,524 | -3,623 |
| Net Income | $-6,980 | $-5,974 | $-4,153 | $-3,524 | $-3,623 |
| EPS Basic Total Ops | -9.00 | -147.38 | -103.75 | -88.16 | -83.66 |
| EPS Basic Continuous Ops | -9.06 | -147.16 | -103.43 | -87.76 | -83.44 |
| EPS Diluted Total Ops | -9.00 | -147.38 | -103.75 | -88.16 | -83.66 |
| EPS Diluted Continuous Ops | -9.06 | -147.16 | -103.43 | -87.76 | -83.44 |
| EBITDA(a) | $-6,866 | $-5,826 | $-3,994 | $-3,366 | $-3,460 |